SGLT2 Inhibitors and HFpEF: A Promise Fulfilled?

Published: 05 October 2022

  • Views:

    Views Icon 204026

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This broadcast 'SGLT2 Inhibitors and HFpEF: A Promise Fulfilled?' looks at the latest results from clinical trials studying pharmacotherapies in people with HFpEF, and current and emerging approaches in HFpEF diagnosis.

 

Dr Shelley Zieroth (St Boniface Hospital, CA) moderates proceedings, and is joined by an outstanding faculty, Prof Carolyn Lam (National Heart Centre, SG), Prof John McMurray (University of Glasgow, UK) Dr Scott Solomon (Brigham and Women's Hospital, US), and Dr Subodh Verma (St. Michael's Hospital, Toronto, CA), for a series of insightful presentations and discussions.

 

Note, the live version of this session was CME accredited; this on-demand version is not.

This programme is supported by an unrestricted educational grant from AstraZeneca.

Learning Objectives

  • To outline current and emerging approaches in HFpEF diagnosis
  • To describe the latest results from clinical trials studying pharmacotherapies in people with HFpEF
  • To explain how to practically personalise HFpEF management with established and novel drugs

Target Audience

  • Primary Care Physicians
  • Endocrinologists
  • Nephrologists
  • Cardiologists
  • Nurses
  • Pharmacists
  • Dietitians
  • Diabetes Educators

More from this programme

Part 1

Welcome and Opening Remarks

1 session
Welcome and Opening Remarks Watch now

Part 2

HFpEF: Unraveling the Mysteries of a Recalcitrant Medical Problem

1 session
HFpEF: Unraveling the Mysteries of a Recalcitrant Medical Problem Watch now

Part 3

SGLT2i in the Treatment of HFpEF: Have They Delivered in Clinical Trials?

1 session
SGLT2i in the Treatment of HFpEF: Have They Delivered in Clinical Trials? Watch now

Part 4

From DAPA-HF to DELIVER: Does Ejection Fraction Really Matter?

1 session
From DAPA-HF to DELIVER: Does Ejection Fraction Really Matter? Watch now

Part 5

From Paper to Practice - Practical Tips for Physicians

1 session
From Paper to Practice - Practical Tips for Physicians Watch now

Part 6

Q&A and Panel Discussion

1 session
Q&A and Panel Discussion Watch now

Faculty Biographies

Carolyn Lam

Carolyn Lam

Professor and Senior Consultant

Prof Carolyn Lam is a Senior Consultant at the Department of Cardiology and Director of Women's Heart Health at the National Heart Centre Singapore, having pioneered the first Women’s Heart Clinic in Singapore. Prof Lam is a world-renowned specialist in heart failure (particularly heart failure with preserved ejection fraction [HFpEF]). Her work in the PARAGON-HF and EMPEROR-Preserved trials led to the first FDA-approved treatment for HFpEF and the first robustly positive clinical outcomes trial in HFpEF to-date.

View full profile